Intranasal corticosteroids should be used for allergic rhinitisBMJ 1998; 317 doi: https://doi.org/10.1136/bmj.317.7173.0d (Published 12 December 1998) Cite this as: BMJ 1998;317:d
The prevalence of allergic rhinitis has increased in the past 30 years and around 20-40% of the population is affected. The condition can cause profound morbidity. On p 1624 Weiner et al report on a systematic review of 16 randomised controlled trials comparing the effectiveness of corticosteroids and oral H1 receptor antagonists (antihistamines) at relieving the symptoms of allergic rhinitis. Intranasal corticosteroids provided greater relief of nasal blockage, discharge, and itch, and of postnasal drip, total nasal symptoms, and global ratings than did antihistamines. Intranasal corticosteroids were also found to be more cost effective.